Search Results - "Geisen, Ulf M"

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort by Geisen, Ulf M, Berner, Dennis K, Tran, Florian, Sümbül, Melike, Vullriede, Lena, Ciripoi, Maria, Reid, Hayley M, Schaffarzyk, Annika, Longardt, Ann C, Franzenburg, Jeanette, Hoff, Paula, Schirmer, Jan H, Zeuner, Rainald, Friedrichs, Anette, Steinbach, Andrea, Knies, Christine, Markewitz, Robert Dh, Morrison, Peter J, Gerdes, Sascha, Schreiber, Stefan, Hoyer, Bimba F

“…In light of the SARS-CoV-2 pandemic, protecting vulnerable groups has become a high priority. Persons at risk of severe disease, for example, those receiving…”
Get more information

The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination by Saggau, Carina, Martini, Gabriela Rios, Rosati, Elisa, Meise, Silja, Messner, Berith, Kamps, Ann-Kristin, Bekel, Nicole, Gigla, Johannes, Rose, Ruben, Voß, Mathias, Geisen, Ulf M., Reid, Hayley M., Sümbül, Melike, Tran, Florian, Berner, Dennis K., Khodamoradi, Yascha, Vehreschild, Maria J.G.T., Cornely, Oliver, Koehler, Philipp, Krumbholz, Andi, Fickenscher, Helmut, Kreuzer, Oliver, Schreiber, Claudia, Franke, Andre, Schreiber, Stefan, Hoyer, Bimba, Scheffold, Alexander, Bacher, Petra

“…SARS-CoV-2 infection and vaccination generates enormous host-response heterogeneity and an age-dependent loss of immune-response quality. How the pre-exposure…”
Get full text

Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series by Geisen, Ulf M., Voß, Mathias, Rose, Ruben, Neumann, Franziska, Bäumler, Carina, Müller, Sina, Paltzow, Lea, Christophersen, Christina M., Münier, Merle, Hildebrand, Elena, Hoff, Paula, Longardt, Ann C., Lorentz, Thomas, Schirmer, Jan H., Sümbül, Melike, Tran, Florian, Berner, Dennis, Fickenscher, Helmut, Gerdes, Sascha, Schreiber, Stefan, Krumbholz, Andi, Hoyer, Bimba F.

Get full text

Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies by Geisen, Ulf M, Sümbül, Melike, Tran, Florian, Berner, Dennis K, Reid, Hayley M, Vullriede, Lena, Ciripoi, Maria, Longardt, Ann C, Hoff, Paula, Morrison, Peter J, Schneider, Verena E, Zeuner, Rainald, Schirmer, Jan H, Steinbach, Andrea, Nikolaus, Susanna, Gerdes, S, Schreiber, Stefan, Bacher, Petra, Hoyer, Bimba F

“…BackgroundThe persistence of the SARS-CoV2 pandemic, partly due to the appearance of highly infectious variants, has made booster vaccinations necessary for…”
Get full text